Vioxx and the Business of Drug Testing

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/4111048/4111049" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Last month, drug company Merck pulled its blockbuster pain reliever Vioxx off the market, citing safety concerns. We take a look at the life of Vioxx and the business of testing drugs.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.